2-(4-(4-氯苯氧基)苯基)乙酸 | 148401-42-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-(4-氯苯氧基)苯基)乙酸
• 中文别名: 2-(2-溴苯基)喹啉-4-羧酸
• 英文名称: 2-(4-(4-chlorophenoxy)phenyl)acetic acid
• 英文别名: [4-(4-chloro-phenoxy)-phenyl]-acetic acid；[4-(4-Chlor-phenoxy)-phenyl]-essigsaeure；(4-(4-chlorophenyl)oxy)phenylacetic acid；2-[4-(4-chlorophenoxy)phenyl]acetic acid
• CAS: 148401-42-7
• 化学式: C₁₄H₁₁ClO₃
• 分子量: 262.693
• InChiKey: XYWCXPKPSPHSAA-UHFFFAOYSA-N

物化性质

• 沸点：
  409.4±30.0 °C(Predicted)
• 密度：
  1.317±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918990090

反应信息

• 作为反应物：
  描述：

  2-(4-(4-氯苯氧基)苯基)乙酸 在 氯化亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 2-[4-(4-chlorophenoxy)phenyl]-N-methoxy-N-methylacetamide
  参考文献：
  名称：

  Synthesis and structure–activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer’s disease

  摘要：

  A series of thiazole derivatives were designed, and prepared to develop RAGE antagonist for the treatment of Alzheimer's disease (AD). SAR studies were performed to optimize inhibitory activity on A beta-RAGE binding. SAR studies showed that introducing an amino group at part A was essential for inhibitory activity on A beta-RAGE binding. Compounds selected from A beta-RAGE binding screening displayed inhibitory activity on A beta transport across BBB. They also showed inhibitory activity against A beta-induced NF-kappa B activation. These results indicated that our derivatives had a potential as therapeutic agent for the treatment of AD. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.022
• 作为产物：
  描述：

  methyl 2-(4-(4-chlorophenoxy)phenyl)acetate 在 sodium hydroxide 、 盐酸 作用下， 以 甲醇 、 水 为溶剂， 以95%的产率得到2-(4-(4-氯苯氧基)苯基)乙酸
  参考文献：
  名称：

  Synthesis and structure–activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer’s disease

  摘要：

  A series of thiazole derivatives were designed, and prepared to develop RAGE antagonist for the treatment of Alzheimer's disease (AD). SAR studies were performed to optimize inhibitory activity on A beta-RAGE binding. SAR studies showed that introducing an amino group at part A was essential for inhibitory activity on A beta-RAGE binding. Compounds selected from A beta-RAGE binding screening displayed inhibitory activity on A beta transport across BBB. They also showed inhibitory activity against A beta-induced NF-kappa B activation. These results indicated that our derivatives had a potential as therapeutic agent for the treatment of AD. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.10.022

文献信息

• Barbituric acid derivatives
  申请人：——

  公开号：US20020187991A1

  公开（公告）日：2002-12-12

  Derivatives of 5,5-disubstituted pyrimidine-2,4,6-trianones are disclosed. These compounds have antitumor and antimetastatic activity.

  5,5-二取代嘧啶-2,4,6-三酮的衍生物已被披露。这些化合物具有抗肿瘤和抗转移活性。
• Preparation of carbon-14 labeled N-(2-ethyl-3-chloro-4-pyridinyl)-4-(4-chlorophenoxy)phenylacetamide
  作者：N. R. Pearson

  DOI：10.1002/(sici)1099-1344(199802)41:2<151::aid-jlcr64>3.0.co;2-r

  日期：1998.2

  A 4-step modified route has been developed for the synthesis of N-(2-ethyl-3-chloro-4-pyridinyl-2-[ 14 C])-4-(4-chlorophenoxy)phenylacetamide ([ 14 C]-1). The key transformation in the sequence is an amination/cyclization pair of reactions that furnished 2-[ 14 C]-4-amino-2-ethylpyridine (4) from 5-[ 14 C]-1-methoxyhept-1-en-3-yn-5-one (3) and ammonia. Amine 4 was then selectively chlorinated to provide

  已开发了一种 4 步改进路线，用于合成 N-(2-乙基-3-氯-4-吡啶基-2-[ 14 C])-4-(4-氯苯氧基)苯基乙酰胺 ([ 14 C]- 1）。序列中的关键转化是胺化/环化反应对，从 5-[ 14 C]-1-甲氧基庚-1-en-3 提供 2-[ 14 C]-4-氨基-2-乙基吡啶 (4) -yn-5-一 (3) 和氨。然后将胺 4 选择性氯化以提供 2-[ 14 C]-4-氨基-3-氯-2-乙基吡啶 (5)，然后在反应中将其与 4-(4-氯苯氧基) 苯乙酸乙基甲酸酐 (6) 偶联由三甲基铝介导以提供所需的放射性标记的苯基乙酰胺[ 14 C]-1。
• Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
  申请人：Hoffmann-La Roche Inc.

  公开号：US06498252B1

  公开（公告）日：2002-12-24

  Compounds of formula I in which R1 represents a substituted or unsubstituted phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, phenylamino or phenylmethyl residue, and R2 represents an optionally substituted aryl or heteroaryl residue, with metallo-proteinase inhibitor activity.

  具有以下化学式I的化合物，其中R1代表取代或未取代的苯氧基、苯硫醚基、苯亚砜基、苯砜基、苯胺基或苯甲基残基，R2代表可选取代的芳基或杂环芳基残基，具有金属蛋白酶抑制剂活性。
• 2,2’-Dipyridylamine: A tripod ligand enabling practical access to diaryl ethers <i>via</i> Cu-catalyzed coupling reaction
  作者：Yuanguang Chen、Huashen Xu、Lu Chen、Anyuan Hou、Guoliang Chen

  DOI：10.1080/00397911.2022.2134797

  日期：2022.11.17

  copper(I)-catalyzed C-O/S coupling reactions of abundant aryl bromines with related phenols or thiophenols. The key to this very discovery is the identification of an N-donor tripod ligand (DPA), and such a reaction allows the conversion of simple starting materials to complex diaryl ethers or diaryl thioethers, which are important synthetic intermediates in the preparation of bioactive molecules.

  摘要 本文首次报道了 2,2'-二吡啶胺 (DPA) 作为一种新型高效的三齿配体，用于促进铜 (I) 催化的丰富芳基溴与相关酚类或苯硫酚的 CO/S 偶联反应。这一发现的关键是鉴定N-供体三脚配体 (DPA)，这种反应允许将简单的起始材料转化为复杂的二芳基醚或二芳基硫醚，它们是制备生物活性分子的重要合成中间体.
• [EN] 4-(ARALKOXY OR ARALKYLAMINO)PYRIDINE PESTICIDES_________________
  申请人：DOWELANCO

  公开号：WO1993005050A1

  公开（公告）日：1993-03-18

  (EN) 4-(Aralkoxy or aralkylamino)pyridines, for example 4-[2-[4-(2,2,2-trifluoroethoxy)phenyl]ethoxy]pyridine, are active against nematodes, insects, mites, and plant pathogens.(FR) Les composés 4-(aralcoxy ou aralkylamino)pyridines, par exemple 4-[2-[4-(2,2,2, tri-fluoroéthoxy)phényl]éthoxy]pyridine sont actifs contre les nématodes, les insectes, les mites et les agents pathogènes végétaux.

  4-(取代基或取代氨基的)吡咯，例如4-[2-[4-(2,2,2-三氟乙氧基)苯基]乙氧基]吡咯，能够对抗蜱虫、lesion无害、昆虫、和植物病原体。 4-(有基团或有取代氨基的)吡咯，例如4-[2-[4-(2,2,2-三氟乙氧基)苯基]乙氧基]吡咯，是抗蜱虫、防治昆虫、虫卵以及植物病原体的有效物质。